Archive for News

Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations

ESMO Congress 2024 Highlights

Mary Crowley Receives $50,000 Grant from Fichtenbaum Charitable Trust

ASCO 2024 Highlights

Event Watch: Runway for Hope 2024

Mary Crowley Featured on My Sweet Charity Blog

Mary Crowley Ranked #1 Phase I Oncology Site by Vial.com

Event Watch: Pushing Hope

Mary Crowley Receives $50,000 from Fichtenbaum Trust Grant

Ethnically and Language Concordant Clinical Trial Educational Intervention to Increase Diversity in Cancer Clinical Trial Participation